Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study.

K, Kaku; T, Itayasu; S, Hiroi; M, Hirayama; Y, Seino

doi:10.1111/j.1463-1326.2011.01460.x

Public

Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study.

Shared by NobleBlocks on Nov 1, 2011 • 12:00 AM UTC

Authors:

Kaku K

Itayasu T

Hiroi S

Abstract

<h4>Aim</h4>To assess the efficacy and safety of alogliptin added to pioglitazone versus pioglitazone monotherapy, in Japanese patients with type 2 diabetes who achieved inadequate glycaemic control on pioglitazone plus diet/exercise.<h4>Methods</h4>Patients were stabilized on pioglitazone 15 or 30 ...

Discussions